16 05, 2023 Daniela Massi et al., Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group. adlitterio663392023-10-17T09:13:03+02:00 Mehr erfahren
12 05, 2023 Francesca Bersani et al., Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity adlitterio663392023-10-17T09:12:09+02:00 Mehr erfahren
11 05, 2023 Giulia Simoncini et al., NRAS-mutated oncocytic benign liver lesion in an organ donor: Pitfalls and troubles in frozen section diagnosis and risk assessment adlitterio663392023-05-11T16:29:32+02:00 Mehr erfahren
4 05, 2023 Büsra Saruhan., Gastrik kanser hastalar?nda mikrosatellite instabilite durumunun retrospektif de?erlendirilmesi:tek merkez deneyimi adlitterio663392023-05-04T14:45:49+02:00 Mehr erfahren
4 05, 2023 Federica Zito Marino et al., NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS. adlitterio663392023-10-17T09:08:15+02:00 Mehr erfahren
1 05, 2023 Elena Orlandi et al., Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment adlitterio663392023-10-17T09:07:01+02:00 Mehr erfahren
21 04, 2023 Diatech Pharmacogenetics will join the Precision Med Exhibition of Dubai on May 23-24/2023 Diatech Pharmacogenetics will join the Precision Med Exhibition of Dubai on May 23-24/2023 Nachrichten, Veranstaltungen Diatech Pharmacogenetics will join the Precision Med Exhibition of Dubai on May 23-24/2023 adlitterio663392023-04-21T17:28:01+02:00 Mehr erfahren
13 04, 2023 Valentina Angerilli et al., HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective adlitterio663392023-04-13T16:24:59+02:00 Mehr erfahren
1 04, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – February and March 2023 adlitterio663392023-06-28T10:54:57+02:00 Mehr erfahren
30 03, 2023 Margherita Vannucchi et al., KRAS Mutations Are Associated with Shortened Survival in Patients with Epithelioid Malignant Pleural Mesothelioma adlitterio663392023-10-17T09:04:54+02:00 Mehr erfahren
